Search Results - "Baz, David Vicente"

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database by Campos‐Balea, Begoña, Castro Carpeño, Javier, Massutí, Bartomeu, Vicente‐Baz, David, Pérez Parente, Diego, Ruiz‐Gracia, Pedro, Crama, Leonardo, Cobo Dols, Manuel

“…Background Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for…”
Get full text

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC by Andric, Zoran, Gálffy, Gabriella, Cobo Dols, Manuel, Szima, Barna, Stojanovic, Goran, Petrovic, Marina, Felip, Enriqueta, Vicente Baz, David, Ponce Aix, Santiago, Juan-Vidal, Oscar, Szalai, Zsuzsanna, Losonczy, Gyorgy, Calles Blanco, Antonio, Bernabe, Reyes, García Ledo, Gema, Aguilar Hernández, Andrés, Duecker, Klaus, Zhou, Dongli, Schroeder, Andreas, Guezel, Guelseren, Ciardiello, Fortunato

“…We present the results of a phase 2a trial of first-line avelumab (anti–programmed death-ligand 1 antibody) plus cetuximab (anti–EGFR antibody) in patients…”
Get full text

Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes by de la Cruz-Merino, Luis, Álvaro, Tomás, Henao-Carrasco, Fernando, Villar Rodríguez, José Luis, Vicente Baz, David, Codes Manuel de Villena, Manuel, Pulla, Mariano Provencio

“…Lymphomas represent a wide group of heterogenic diseases with different biological and clinical behavior. The underlying microenvironment-specific composition…”
Get full text

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib by Serrano, César, García‐del‐Muro, Xavier, Valverde, Claudia, Sebio, Ana, Durán, José, Manzano, Aránzazu, Pajares, Isabel, Hindi, Nadia, Landolfi, Stefania, Jiménez, Laura, Rubió‐Casadevall, Jordi, Estival, Anna, Lavernia, Javier, Safont, María José, Pericay, Carles, Díaz‐Beveridge, Roberto, Martínez‐Marín, Virginia, Vicente‐Baz, David, Vivancos, Ana, Hernández‐Losa, Javier, Arribas, Joaquín, Carles, Joan

“…Background Oncogenic KIT/PDGFRA signaling inhibition with imatinib achieves disease control in most patients with advanced/metastatic gastrointestinal stromal…”
Get full text

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain by Arriola, Edurne, García Gómez, Ramón, Diz, Pilar, Majem, Margarita, Martínez Aguillo, Maite, Valdivia, Javier, Paredes, Alfredo, Sánchez-Torres, José Miguel, Peralta Muñoz, Sergio, Barneto, Isidoro, Gutierrez, Vanesa, Andrade Santiago, Jesús Manuel, Aparisi, Francisco, Isla, Dolores, Ponce, Santiago, Vicente Baz, David, Artal, Angel, Amador, Mariluz, Provencio, Mariano

“…Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several…”
Get full text

Análisis de las intervenciones nutricionales en el proceso asistencial del paciente oncológico en Andalucía: el proyecto NOA by García Luna, Pedro Pablo, Calañas Continente, Alfonso, Villarrubia Pozo, Ana, Jiménez Lorente, Carmen Pilar, Vicente Baz, David, Castanedo, Olaya Isabel, Salvador Bofill, Javier, Rabat Restrepo, Juana María, Díaz Gómez, Laura, Mediano Rambla, María Dolores, Brozeta Benítez, Teresa, Muñoz Lucero, Teresa, Olveira, Gabriel

“…Resumen Introducción: la desnutrición en los pacientes oncológicos puede conllevar una reducción de la calidad de vida del paciente y un aumento de la…”
Get full text

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study by Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

“…Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or…”
Get full text

Irinotecan-Induced Dysarthria by Baz, David Vicente, Bofill, Javier Salvador, Nogueira, José Andrés Moreno

“…Cancer Chemother Pharmacol 1998;41:4648.(5) Naranjo CA, Busto U, Pharm D, Sellers EM,Sandor P, Ruiz I, et al. A method for estimat-Fig. 1…”
Get full text

An open-label, multicenter, phase 2 study of the safety and efficacy of navtemadlin (KRT-232) in patients with TP53 wild-type relapsed/refractory small cell lung cancer by Dowlati, Afshin, Juan-Vidal, Oscar, Hiret, Sandrine, Rittmeyer, Achim, Sukumaran, Shawgi, Vicente Baz, David, Rios-Perez, Jorge Arturo, Harris, Eric Michael, McCune, Steven L., Johnson, Melissa Lynne, Croft, Brandon, McGreivy, Jesse S., Rothbaum, Wayne P., de Castro Carpeño, Javier

“…TPS8600 Background: Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor characterized by early metastasis and a high recurrence rate with…”
Get full text

Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification ( MET amp) detected by liquid biopsy (LBx) by Le, Xiuning, Paz-Ares, Luis, Van Meerbeeck, Jan, Viteri Ramirez, Santiago, Cabrera Galvez, Carlos, Vicente Baz, David, Kim, Young-Chul, Kang, Jin-Hyoung, Stroh, Christopher, Juraeva, Dilafruz, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Paik, Paul K.

“…9121 Background: Tepotinib, a potent, highly selective, oral, MET inhibitor, showed meaningful activity in patients (pts) with NSCLC with high-level METamp by…”
Get full text

Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification ( MET amp) by Le, Xiuning, Paz-Ares, Luis G., Van Meerbeeck, Jan, Viteri, Santiago, Cabrera Galvez, Carlos, Vicente Baz, David, Kim, Young-Chul, Kang, Jin-Hyoung, Schumacher, Karl-Maria, Karachaliou, Niki, Adrian, Svenja, Bruns, Rolf, Paik, Paul K.

“…Abstract only 9021 Background: METamp is an oncogenic driver occurring in 1–5% of NSCLCs that confers a poor prognosis and lacks approved targeted therapies…”
Get full text

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study by Ahn, Myung-Ju, Tanaka, Kentaro, Paz-Ares, Luis, Cornelissen, Robin, Girard, Nicolas, Pons-Tostivint, Elvire, Vicente Baz, David, Sugawara, Shunichi, Cobo, Manuel, Pérol, Maurice, Mascaux, Céline, Poddubskaya, Elena, Kitazono, Satoru, Hayashi, Hidetoshi, Hong, Min Hee, Felip, Enriqueta, Hall, Richard, Juan-Vidal, Oscar, Brungs, Daniel, Lu, Shun, Garassino, Marina, Chargualaf, Michael, Zhang, Yong, Howarth, Paul, Uema, Deise, Lisberg, Aaron, Sands, Jacob

“…The randomized, open-label, global phase III TROPION-Lung01 study compared the efficacy and safety of datopotamab deruxtecan (Dato-DXd) versus docetaxel in…”
Get full text

Results from a second-line (2L) NSCLC cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1 by Paz-Ares, Luis G., Kim, Tae Min, Vicente Baz, David, Felip, Enriqueta, Lee, Dae Ho, Lee, Ki Hyeong, Lin, Chia-Chi, Di Nicola, Massimo A., Alvarez Alvarez, Rosa Maria, Dussault, Isabelle, Helwig, Christoph, Ojalvo, Laureen, Gulley, James L., Cho, Byoung Chul

“…Abstract only…”
Get full text

Abstract CT051: Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen mRNA vaccine BNT116 + docetaxel in patients with advanced non-small cell lung cancer by Öven, Bala Başak, Baz, David Vicente, Wolf, Jürgen, Ates, Ozturk, Göker, Erdem, Brück, Patrick, Wenger, Michael, Munshi, Neru, Tsyhankova, Iryna, Kaczorowska, Malgorzata, Schell, Thomas, Markman, Janet L., Yang, Huyuan, Türeci, Özlem, Şahin, Uğur, Forde, Patrick, Atmaca, Akin

“…Background: Non-small cell lung cancer (NSCLC) is often diagnosed late with many patients (pts) not responding to first line therapy or only responding for a…”
Get full text

Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B by Le, Xiuning, Paz-Ares, Luis G, Van Meerbeeck, Jan, Viteri, Santiago, Galvez, Carlos Cabrera, Smit, Egbert F, Garassino, Marina, Veillon, Remi, Baz, David Vicente, Pradera, Jose Fuentes, Sereno, María, Kozuki, Toshiyuki, Kim, Young-Chul, Yoo, Seung Soo, Han, Ji-Youn, Kang, Jin-Hyoung, Son, Choon-Hee, Choi, Yoon Ji, Stroh, Christopher, Juraeva, Dilafruz, Vioix, Helene, Bruns, Rolf, Otto, Gordon, Johne, Andreas, Paik, Paul K

“…High-level MET amplification (METamp) is a primary driver in ∼1%-2% of non-small cell lung cancers (NSCLCs). Cohort B of the phase 2 VISION trial evaluates…”
Get full text

Analysis of nutritional interventions in the care process of oncological patients in Andalusia - the NOA project by García Luna, Pedro Pablo, Calañas Continente, Alfonso, Villarrubia Pozo, Ana, Jiménez Lorente, Carmen Pilar, Vicente Baz, David, Castanedo, Olaya Isabel, Salvador Bofill, Javier, Rabat Restrepo, Juana María, Díaz Gómez, Laura, Mediano Rambla, María Dolores, Brozeta Benítez, Teresa, Muñoz Lucero, Teresa, Olveira, Gabriel

“…malnutrition in cancer patients can lead to a reduction in patient quality of life, increased morbidity and mortality, and associated healthcare costs. to…”
Get full text

Immune Microenvironment in Colorectal Cancer : A New Hallmark to Change Old Paradigms by Henao Carrasco, Fernando, Nogales Fernández, Esteban, de la Cruz-Merino, Luis, Pulido, Enrique Grande, Codes Manuel de Villena, Manuel, Reina Zoilo, Juan José, Vicente Baz, David

“…Impact of immune microenvironment in prognosis of solid tumors has been extensively studied in the last few years. Specifically in colorectal carcinoma,…”
Get full text

ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort by Vicente-Baz, David, Paredes, Alfredo, Morán, Teresa, Massuti, Bartomeu, Reguart, Noemí, Álvarez, Rosa, Insa, Amelia, Juan-Vidal, Oscar, Artal, Ángel, Esteban, Emilio, García-Campelo, Rosario, Ortega-Granados, Ana L, Diz, Pilar, González-Larriba, Jose L, Terrasa, Josefa, de Las Peñas, Ramón, Rodríguez-Abreu, Delvys, Callejo, Ángel, Márquez, Gloria, Provencio, Mariano

“…Osimertinib has proven efficacy in EGFR T790M mutation-positive non-small cell lung cancer (NSCLC) patients; however, its benefits have not been evaluated in a…”
Get more information

Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms by Pulido, Enrique Grande, Reina Zoilo, Juan José, Nogales Fernández, Esteban, Vicente Baz, David, Henao Carrasco, Fernando, de la Cruz-Merino, Luis, Codes Manuel de Villena, Manuel

“…Impact of immune microenvironment in prognosis of solid tumors has been extensively studied in the last few years. Specifically in colorectal carcinoma,…”
Get full text

Collision tumour. adenocarcinoma and synchronous MALT gastric lymphoma by Vicente Baz, David, Contreras, José A, Maestro, Eva, Añón, María J

Get more information